124 related articles for article (PubMed ID: 36967240)
1. Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomes.
Zona E; Jorgenson M; Dolma S; Santos A; Garg N; Aziz F; Mohamed M; Saddler CM; Smith JA; Mandelbrot D; Parajuli S
Clin Transplant; 2023 Jun; 37(6):e14979. PubMed ID: 36967240
[TBL] [Abstract][Full Text] [Related]
2. In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes.
Yousif EAI; Muth B; Manchala V; Turk J; Blazel J; Bloom M; Garg N; Aziz F; Mohamed M; Djamali A; Mandelbrot D; Parajuli S
Clin Transplant; 2022 Sep; 36(9):e14779. PubMed ID: 35848635
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis.
Leeaphorn N; Garg N; Thamcharoen N; Khankin EV; Cardarelli F; Pavlakis M
Am J Transplant; 2019 Feb; 19(2):573-584. PubMed ID: 30431703
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcomes of BK viremia among deceased donor kidney transplant recipients based on donor characteristics.
Breyer I; Dodin B; Djamali A; Jorgenson MR; Garg N; Aziz F; Mohamed MA; Mandelbrot DA; Parajuli S
Transpl Infect Dis; 2022 Feb; 24(1):e13768. PubMed ID: 34825437
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
[TBL] [Abstract][Full Text] [Related]
7. Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.
Magua W; Johnson AC; Karadkhele GM; Badell IR; Vasanth P; Mehta AK; Easley KA; Newell KA; Rickert JB; Larsen CP
Transpl Infect Dis; 2022 Dec; 24(6):e13983. PubMed ID: 36321801
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes.
Kleiboeker HL; Jorgenson MR; Leverson GE; Rice JP; Saddler CM; Smith JA; Al-Adra D
Transpl Infect Dis; 2022 Aug; 24(4):e13898. PubMed ID: 35780512
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft function.
Freedman SR; Ravichandran BR; Masters BM; Bromberg JS; Haririan A; Saharia KK; Heil EL; Sparkes T
Transpl Infect Dis; 2019 Aug; 21(4):e13125. PubMed ID: 31165548
[TBL] [Abstract][Full Text] [Related]
11. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
12. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Hasegawa J; Hatakeyama S; Wakai S; Omoto K; Okumi M; Tanabe K; Mieno M; Shirakawa H
Int J Infect Dis; 2017 Dec; 65():50-56. PubMed ID: 28986314
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
14. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.
Brennan DC; Garlock KA; Lippmann BA; Buller RS; Gaudreault-Keener M; Lowell JA; Miller SB; Shenoy S; Howard TK; Storch GA
J Am Soc Nephrol; 1997 Jan; 8(1):118-25. PubMed ID: 9013456
[TBL] [Abstract][Full Text] [Related]
15. Low dose valganciclovir as cytomegalovirus prophylaxis in post-renal transplant recipients induced with alemtuzumab: A single-center study.
Korneffel K; Mitro G; Buschor K; Rees M; Ortiz J
Transpl Immunol; 2019 Oct; 56():101226. PubMed ID: 31344441
[TBL] [Abstract][Full Text] [Related]
16. Kidney transplant from hepatitis C viremic donors into aviremic recipients and risk for post-transplant BK and cytomegalovirus infection.
Daloul R; Schnelle K; Von Stein L; Logan A; Singh P; Yenebere P; Pesavento T; Washburn K
Transpl Infect Dis; 2022 Aug; 24(4):e13887. PubMed ID: 35752929
[TBL] [Abstract][Full Text] [Related]
17. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
[TBL] [Abstract][Full Text] [Related]
18. Are the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
Rafferty H; Murray MJ; Tam JCH; Macfarlane A; Smith C; Lumley SF; Atabani S; McKeating JA; Sharma D; Reeves M; Whitmore D; Griffiths P
J Infect Dis; 2022 Aug; 226(2):357-365. PubMed ID: 35184187
[TBL] [Abstract][Full Text] [Related]
19. Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort.
Pullerits K; Garland S; Rengarajan S; Guiver M; Chinnadurai R; Middleton RJ; Chukwu CA; Kalra PA
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366504
[TBL] [Abstract][Full Text] [Related]
20. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
